Organization
Taiwan Liposome Company
3 clinical trials
Clinical trial
A Phase 2, Open-label, Pharmacokinetic Study of a Single Intra-articular Administration of TLC599 in Subjects With Mild to Moderate Osteoarthritis of the KneeStatus: Completed, Estimated PCD: 2023-11-07
Clinical trial
A Phase IIa, Randomized, Double Blinded, Placebo Controlled, Dose Finding Study for Single Dose Administration of TLC599 in Patients With Osteoarthritis (OA) of KneeStatus: Completed, Estimated PCD: 2018-07-04
Clinical trial
A Phase 2/3, Randomized, Double-blind, Comparator- and Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TLC590 for Postsurgical Pain Management Following Inguinal Hernia RepairStatus: Not yet recruiting, Estimated PCD: 2025-12-01